Skip to the page

Data / Form D filings / ALT Bioscience LLC

ALT Bioscience LLC: Form D filings

ALT Bioscience LLC, a biotechnology company in Lexington, KY, filed 6 Form D notices with the SEC between 2009 and 2015. The latest, on June 26, 2015, reports $6.4 million sold of a $6.8 million offering to 42 investors.

Find out what ALT Bioscience LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
315 South Broadway, Suite 100, Lexington, KY, 40508
Phone
(859) 388-9445
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Kentucky
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1424900

The full lists. Form D filings in Kentucky: 216 rows, $10.80, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 26, 2015Amendment$6,800,000$6,377,770$422,23042Feb 22, 2013sec.gov
Jan 16, 2014New notice$6,800,000$1,446,072$5,353,92824Feb 22, 2013sec.gov
Mar 28, 2011New notice$1,699,999$1,699,999$028Jan 31, 2011sec.gov
Sep 20, 2010New notice$920,190$920,190$027Feb 1, 2010sec.gov
Mar 8, 2010New notice$1,200,000$1,079,815$120,18519Aug 3, 2009sec.gov
Nov 13, 2009New notice$853,501$853,501$018Dec 1, 2008sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David McClureExecutive Officer
Leslie HerzogExecutive Officer
Angela ChapmanExecutive Officer
Russell SecterExecutive Officer
Tony Burgess-CasslerExecutive Officer

Every Form D from the week of Jun 22, 2015 · All recent filings in Kentucky · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ALT Bioscience LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.